Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. Th...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DESHPANDE, RAJENDRA P WANG, HAIXIA LI, JIE JACK QIAN, XINHUA ROBL, JEFFREY A GALELLA, MICHAEL KENNEDY, LAWRENCE J KOLLA, LAXMA R WEI, CHENKOU CANN, REGINALD O LI, JAMES J LI, JUN |
| description | Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds of formula I: or stereoisomers or pharmaceutically acceptable salts thereof, wherein G, Q, X, Y, R |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2008309101BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2008309101BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2008309101BB23</originalsourceid><addsrcrecordid>eNqNyr0KwjAUhuEsDqLewxlcC0m76GjFv73OJTVf7YGSE5IMxqsXxAtweuHhXapLF9m-ZZZQIjv2IGOqAdnSVFyUV0kZUdiRwxee8DaBcgmgG7GfeOAsMa3VYrRzwubXldqeT93xWiFIjxTsAx65P9xrrXeN3htt2rZu_tw-8NE11A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors</title><source>esp@cenet</source><creator>DESHPANDE, RAJENDRA P ; WANG, HAIXIA ; LI, JIE JACK ; QIAN, XINHUA ; ROBL, JEFFREY A ; GALELLA, MICHAEL ; KENNEDY, LAWRENCE J ; KOLLA, LAXMA R ; WEI, CHENKOU ; CANN, REGINALD O ; LI, JAMES J ; LI, JUN</creator><creatorcontrib>DESHPANDE, RAJENDRA P ; WANG, HAIXIA ; LI, JIE JACK ; QIAN, XINHUA ; ROBL, JEFFREY A ; GALELLA, MICHAEL ; KENNEDY, LAWRENCE J ; KOLLA, LAXMA R ; WEI, CHENKOU ; CANN, REGINALD O ; LI, JAMES J ; LI, JUN</creatorcontrib><description>Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds of formula I: or stereoisomers or pharmaceutically acceptable salts thereof, wherein G, Q, X, Y, R</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131212&DB=EPODOC&CC=AU&NR=2008309101B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131212&DB=EPODOC&CC=AU&NR=2008309101B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DESHPANDE, RAJENDRA P</creatorcontrib><creatorcontrib>WANG, HAIXIA</creatorcontrib><creatorcontrib>LI, JIE JACK</creatorcontrib><creatorcontrib>QIAN, XINHUA</creatorcontrib><creatorcontrib>ROBL, JEFFREY A</creatorcontrib><creatorcontrib>GALELLA, MICHAEL</creatorcontrib><creatorcontrib>KENNEDY, LAWRENCE J</creatorcontrib><creatorcontrib>KOLLA, LAXMA R</creatorcontrib><creatorcontrib>WEI, CHENKOU</creatorcontrib><creatorcontrib>CANN, REGINALD O</creatorcontrib><creatorcontrib>LI, JAMES J</creatorcontrib><creatorcontrib>LI, JUN</creatorcontrib><title>Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors</title><description>Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds of formula I: or stereoisomers or pharmaceutically acceptable salts thereof, wherein G, Q, X, Y, R</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyr0KwjAUhuEsDqLewxlcC0m76GjFv73OJTVf7YGSE5IMxqsXxAtweuHhXapLF9m-ZZZQIjv2IGOqAdnSVFyUV0kZUdiRwxee8DaBcgmgG7GfeOAsMa3VYrRzwubXldqeT93xWiFIjxTsAx65P9xrrXeN3htt2rZu_tw-8NE11A</recordid><startdate>20131212</startdate><enddate>20131212</enddate><creator>DESHPANDE, RAJENDRA P</creator><creator>WANG, HAIXIA</creator><creator>LI, JIE JACK</creator><creator>QIAN, XINHUA</creator><creator>ROBL, JEFFREY A</creator><creator>GALELLA, MICHAEL</creator><creator>KENNEDY, LAWRENCE J</creator><creator>KOLLA, LAXMA R</creator><creator>WEI, CHENKOU</creator><creator>CANN, REGINALD O</creator><creator>LI, JAMES J</creator><creator>LI, JUN</creator><scope>EVB</scope></search><sort><creationdate>20131212</creationdate><title>Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors</title><author>DESHPANDE, RAJENDRA P ; WANG, HAIXIA ; LI, JIE JACK ; QIAN, XINHUA ; ROBL, JEFFREY A ; GALELLA, MICHAEL ; KENNEDY, LAWRENCE J ; KOLLA, LAXMA R ; WEI, CHENKOU ; CANN, REGINALD O ; LI, JAMES J ; LI, JUN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2008309101BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2013</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DESHPANDE, RAJENDRA P</creatorcontrib><creatorcontrib>WANG, HAIXIA</creatorcontrib><creatorcontrib>LI, JIE JACK</creatorcontrib><creatorcontrib>QIAN, XINHUA</creatorcontrib><creatorcontrib>ROBL, JEFFREY A</creatorcontrib><creatorcontrib>GALELLA, MICHAEL</creatorcontrib><creatorcontrib>KENNEDY, LAWRENCE J</creatorcontrib><creatorcontrib>KOLLA, LAXMA R</creatorcontrib><creatorcontrib>WEI, CHENKOU</creatorcontrib><creatorcontrib>CANN, REGINALD O</creatorcontrib><creatorcontrib>LI, JAMES J</creatorcontrib><creatorcontrib>LI, JUN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DESHPANDE, RAJENDRA P</au><au>WANG, HAIXIA</au><au>LI, JIE JACK</au><au>QIAN, XINHUA</au><au>ROBL, JEFFREY A</au><au>GALELLA, MICHAEL</au><au>KENNEDY, LAWRENCE J</au><au>KOLLA, LAXMA R</au><au>WEI, CHENKOU</au><au>CANN, REGINALD O</au><au>LI, JAMES J</au><au>LI, JUN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors</title><date>2013-12-12</date><risdate>2013</risdate><abstract>Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds of formula I: or stereoisomers or pharmaceutically acceptable salts thereof, wherein G, Q, X, Y, R</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2008309101BB2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-10T23%3A52%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DESHPANDE,%20RAJENDRA%20P&rft.date=2013-12-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2008309101BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |